Country soon to get world’s first DNA-plasmid vaccine by Zydus Cadilla: Chairman COVID-19 NTAGI

Zydus Cadila vaccine to be available by September

Chairman of COVID-19 Working Group of the National Technical Advisory Group on Immunization (NTAGI), Dr Narendra Kumar Arora has said that the country will soon have the world’s first DNA-plasmid vaccine by Zydus Cadila which has been Made in India.

The other vaccine that the government can expect soon is Biological E – a protein subunit vaccine, he further informed that the trials of these vaccines have been quite encouraging and they are hopeful that this vaccine will be available by September this year.

The Indian m-RNA vaccine which can be stored at temperature 2 to 8 Degree Celsius should also be available by September.

He informed that two other vaccines namely Novavax by Serum Institute of India, SII and Johnson and Johnson may also be expected soon.

He said, by the third week of July, the production capacity of Bharat Biotech and SII are going to be increased phenomenally which will enhance the vaccine supply in the country.

Dr Arora informed that by August, we are expected to procure 30 to 35 crore doses of vaccines in a month and this will enable us to vaccinate one crore persons per day.

Dr Arora spoke on these and various other facets of India’s COVID-19 vaccination drive, in an interview with the Department of Science and Technology’s OTT – India Science Channel.

Tags : #ZydusCadila #MRNAVaccine #DNAPlasmidVaccine #Novavax #BiologicaE

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Deworming in Children: A Crucial Step Towards Healthy GrowthFebruary 07, 2025
AI-powered blue-collar hiring platform Vahan.ai secures investment from APAC HR services leader Persol Group amid booming gig economy in India; plans to develop AI recruitment technology to support 8 major Indian languages February 07, 2025
Scars That Never Heal: The Painful Reality of Female Genital MutilationFebruary 06, 2025
Maharashtra’s Healthcare Betrayal: Why Are Crucial Funds Going Unused?February 06, 2025
1vision, 1 mission: Avaada Foundation’s CSR initiatives are powering communities and delivering sustainable progress across 5 key focus areasFebruary 06, 2025
Top 5 Technology Brands that are Transforming the Cancer Care Journeys for Hospitals and PatientsFebruary 06, 2025
Women's Wellness brand NUA Raises Rs 35 Crore in Pre-Series C led by Mirabilis Investment TrustFebruary 06, 2025
8 Effective Ways to Minimize Postpartum ComplicationsFebruary 06, 2025
Does Where You Live Decide Your Fate? The Urban-Rural Breast Cancer Divide in IndiaFebruary 06, 2025
Nepal leads the world with largest pictorial health warnings on all tobacco productsFebruary 05, 2025
Fleetguard Filters Private Limited Recognized for Excellence in CSR at Navabharat’s 4th CSR ConclaveFebruary 05, 2025
Six new regions of the Russian Federation are set to connect to Moscow's AI medical services platform, MosMedAIFebruary 04, 2025
Six new regions of the Russian Federation are set to connect to Moscow's AI medical services platform, MosMedAIFebruary 04, 2025
Ashok Leyland Reinforces ESG Commitment, Ranked No. 1 Globally in Sustainalytics’ RatingsFebruary 04, 2025
Calcium Supplements: Do You Really Need Them?February 04, 2025
Digital Diagnostics Doubles Its Foreign Publication Count in 2024February 04, 2025
World Cancer Day quotesFebruary 04, 2025
India can take a big leap in Cancer Care with Improved access to treatment and People-centered Approach: ExpertsFebruary 04, 2025
Lilly India appoints Winselow Tucker as the President and General ManagerFebruary 04, 2025
Driving Excellence in Clinical Research: ISCR's 18th Annual Conference Highlights Innovation, Technology, and Patient-CentricityFebruary 04, 2025